On the origin of serum CD26 and its altered concentration in cancer patients.
about
Dipeptidyl peptidase-4 and kidney fibrosis in diabetesDPP4 in DiabetesPotential role of dipeptidyl peptidase IV in the pathophysiology of heart failureRegulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Mononuclear cells and vascular repair in HHTFunctional similarities between the dictyostelium protein AprA and the human protein dipeptidyl-peptidase IV.Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetesDipeptidyl peptidase IV and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.The nonglycemic actions of dipeptidyl peptidase-4 inhibitorsPleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular systemFunctional protease profiling for diagnosis of malignant disease.Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo.Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cellsDipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.Potential of soluble CD26 as a serum marker for colorectal cancer detection.Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancerSerum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study.Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker.The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose.Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian SubjectsSerum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian SubjectsHigh Levels of Serum DPP-4 Activity Are Associated with Low Bone Mineral Density in Obese Postmenopausal Women.Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndromeThe serine protease, dipeptidyl peptidase IV as a myokine: dietary protein and exercise mimetics as a stimulus for transcription and releasePlasma dipeptidyl peptidase IV activity and measures of body composition in apparently healthy people.Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellentAssociation of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro.Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung diseaseIncreased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China National Diabetes and Metabolic Disorders Study.DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis.
P2860
Q26766089-D17A4756-B9E3-40F6-BD0E-3C1B14601E0AQ26797335-45855B5F-117D-4E5A-89DF-1EEFFE51E09FQ26829634-73BCA25B-CE25-49D9-9DD4-E0E9310B0E1BQ28072580-F2EC5D37-64E1-4CAD-8903-D85DDA808C31Q28084374-47807D82-019E-4942-B6CD-5DAD39598308Q30396851-9FF4BCEC-C1C5-4A4B-AB48-482BD65A81E4Q33566802-02E5FFC0-6080-47BF-980B-B09CB8E72501Q33804704-CED8364B-D9AA-47FA-976B-4C1A906EDF42Q34029715-F64F307D-8E78-4565-A8EB-BA3B4ABAE892Q34062829-2FFED833-B88F-40B9-BE2B-A4AD5F72434EQ34116114-7D30D41A-EC41-472F-87AD-A1C2A49AF73BQ34166374-BA6EF4D8-6042-4872-990B-BF5AD3F0B5D1Q34386621-CEFF7469-397B-4869-ACC7-CD76924D3502Q34468372-00B80799-A9A9-45F7-8C58-4D6B244AB2DEQ34512293-42567F4A-6CFB-4909-BBC0-5A91FB6371E8Q34700818-B2FA0856-276C-4E0F-A78E-B1AA3F73E4F9Q35063234-159A6620-5E3A-4EEF-A16C-C41F89719E46Q35113393-B8561715-D511-423B-97EC-A62A1B2327E7Q35195876-D5F8322E-06A0-4B65-92DE-EA2B452FDFC3Q35620753-CC4EBB81-29BD-4D62-9652-604974013D2EQ35677316-8C5BF06D-9EE4-40CC-9DFE-3094C87947FFQ35692539-1FF40DD5-6FE8-4659-A22C-875F597751DFQ35723683-02429066-8CA8-45E6-A051-352F863BC45CQ35808043-1BE4C1F7-C8FB-4401-88D5-6A5B4412824FQ35809359-A56F1246-5473-4B85-A17E-1052F890CC37Q35855698-406CD487-0192-4C6B-8888-D099EA9F4676Q35998458-18041EEB-C577-495A-9707-8E3DAFE7867EQ36170755-EECA63F4-A60E-48C3-935E-AC074155B9BBQ36717067-40C8C039-1A1D-4F7B-96D3-8BF13C3618A0Q36799402-C116F213-A5F4-44FC-B148-33BE41FF8319Q37043350-312E17A9-5F52-4C93-A6B8-762C7DC262E2Q37096820-D33DF5AE-9D87-45D5-8C6B-955BC50C9F03Q37130392-EC11375E-1330-4F0C-89BE-A86A527CD80FQ37221100-A9D14DE4-799B-4F19-BB20-478A1314BBECQ37331331-0DE5BBFA-AB56-4E78-BE43-413F93C97272Q37410661-CE6E9837-3378-403D-B840-B884445E8CAEQ37488703-AC6A20DC-04AA-494C-B639-8001EE94C525Q37559570-0A9F8CC5-EC76-4A6D-AA8E-90A5EA85EE46Q37649683-549589A0-CD7B-4710-AD14-6A557C4FB54BQ37702777-55A6582F-1157-480B-B264-FE43B488C9FA
P2860
On the origin of serum CD26 and its altered concentration in cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
On the origin of serum CD26 and its altered concentration in cancer patients.
@en
On the origin of serum CD26 and its altered concentration in cancer patients.
@nl
type
label
On the origin of serum CD26 and its altered concentration in cancer patients.
@en
On the origin of serum CD26 and its altered concentration in cancer patients.
@nl
prefLabel
On the origin of serum CD26 and its altered concentration in cancer patients.
@en
On the origin of serum CD26 and its altered concentration in cancer patients.
@nl
P2860
P1476
On the origin of serum CD26 and its altered concentration in cancer patients
@en
P2093
Montserrat Nogueira
P2860
P2888
P304
P356
10.1007/S00262-009-0728-1
P577
2009-06-26T00:00:00Z